The largest database of trusted experimental protocols

F9911

Manufactured by Merck Group
Sourced in United States

The F9911 is a laboratory equipment product manufactured by Merck Group. It is a precision weighing scale designed for accurate measurement of small samples. The core function of the F9911 is to provide reliable and consistent weight measurements.

Automatically generated - may contain errors

2 protocols using f9911

1

Fibronectin Binding Domain Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
One hundred μl each of recombinant fibrinogen (F3879, sigma), full-length fibronectin (F2006, Sigma), HBD (F9911, Sigma) and CBD (F0162, 45-kDa, Sigma) domains of fibronectin at a concentration of 5 μg/ml in 50mM Na2CO3, pH 9.6 was coated onto ELISA plates (IWAKI) at 4 °C overnight. After three-time washes with PBS, the plate was blocked with 1% (w/v) BSA in 50 mM Na2CO3 (pH 9.6) and incubated at room temperature for 1h. The ELISA plate was then washed three times and then incubated with 3xFlag-tagged, recombinant VpadF truncation fragments at room temperature for 1 h. After triple washes, 100 μl mouse α-3xFlag-HRP antibody (diluted 1:1000 0) was added to each well and incubated at room temperature for 1 h. 100 μl TMB (T4444, sigma) was added to each well for color development (5 min, room temperature). After quenching with 100 μl H2SO4 (1 M), absorbance was read at 450 nm. BSA was coated simultaneously as negative control.
+ Open protocol
+ Expand
2

Fibronectin Fragment-Induced Inflammation in IVD Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the stimulation experiments, IVD cells were cultured for 24 h in a 6-well plate at a density of 2 × 105 cells/well in DMEM/F12 supplemented with 1% Antibiotic-Antimycotic and 10% FCS. On the next day, cells were serum starved in media supplemented with Polymyxin B (100 units/mL, 81271, Sigma-Aldrich) with or without Sparstolonin B (SsnB, 25 μM, TRL-2/TRL-4 inhibitor, SML1767, Sigma-Aldrich) for 2 h prior to stimulation with FnF. Afterwards, cells were treated with 30 kDa proteolytic fragments from human plasma fibronectin (FnF, 500 nmol/L, F9911, Sigma-Aldrich) or recombinant canine IL-1β, which was used as positive inflammation control (10 ng/ml, 3747-CL-025, R&D Systems, Inc., Minneapolis, MN 55413, USA) for 18h. Untreated NP cells served as a negative control group, NP cells treated with Sparstolonin B alone were used as a control to the combination treatment of FnF, and Sparstolonin B. Used concentrations were based on the range of FnF found in IVDs during degeneration (19 (link), 29 (link)). After the incubation time, media supernatants were collected, and cells were lysed using RLT Lysis Buffer (79,216, Qiagen, Hilden, Germany). Both cell lysates and supernatants were stored at −80°C until further analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!